Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Taps Former Instrument Executive to be CTO

NEW YORK, Aug. 7 – Microfluidics startup Fluidigm has appointed Douglas Modlin to the position of chief technology officer and vice president of research and development, the company said on Tuesday.  

Modlin previously served as vice president of instrumentation technology research and development at Molecular Devices Corporation. He has also worked in various capacities at LJL BioSystems, Affymax, and Affymetrix.

Fluidigm, formerly known as Mycometrix, has developed a technique for building "lab-on-a-chip" technology using flexible rubber slabs that can efficiently pump fluids through microscopic channels.

The technology has applications in cell sorting and mixing, and perhaps also in protein separation, sample preparation, and single molecule analysis.

In July, Fluidigm said that it would partner with Axon Instruments to develop a chip and instrument platform for handling and manipulating cells in experiments to learn how drug targets function in cells.

Fluidigm, based in South San Francisco, Calif., plans to release its chips commercially sometime in 2002, the company said.

Currently, it has developed starter kits that it sends to researchers, who in turn help the company develop new applications for the chips.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.